Eledon Pharmaceuticals, Inc. Proceeds from Sale and Maturity of Marketable Securities
Eledon Pharmaceuticals, Inc. (ELDN) reported Proceeds from Sale and Maturity of Marketable Securities of $4.17 million for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-03.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities · last filed 2017-05-03
- Eledon Pharmaceuticals, Inc. proceeds from sale and maturity of marketable securities for the quarter ending 2017-03-31 was $4.17M.
- Eledon Pharmaceuticals, Inc. proceeds from sale and maturity of marketable securities for the quarter ending 2016-12-31 was $11.90M.
- Eledon Pharmaceuticals, Inc. proceeds from sale and maturity of marketable securities for the quarter ending 2016-09-30 was $15.65M.
- Eledon Pharmaceuticals, Inc. proceeds from sale and maturity of marketable securities for fiscal 2016 was $36.20M.
| Period end | Proceeds from Sale and Maturity of Marketable Securities 3 month | Proceeds from Sale and Maturity of Marketable Securities 6 month | Proceeds from Sale and Maturity of Marketable Securities 9 month | Proceeds from Sale and Maturity of Marketable Securities 12 month |
|---|---|---|---|---|
| 2017-03-31 | $4.17M 10-Q · filed 2017-05-03 | $16.08M derived: sum of 2 quarters · filed 2017-05-03 | $31.73M derived: sum of 3 quarters · filed 2017-05-03 | |
| 2016-12-31 | $11.90M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03 | $27.55M derived: sum of 2 quarters · filed 2017-03-03 | $36.20M 10-K · filed 2017-03-03 | |
| 2016-09-30 | $15.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $24.30M 10-Q · filed 2016-11-03 | ||
| 2016-06-30 | $8.65M 10-Q · filed 2016-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |